Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice. 1978

H Cantor, and L McVay-Boudreau, and J Hugenberger, and K Naidorf, and F W Shen, and R K Gershon

We have shown that (a) purified T-helper cells induce cells of another T-cell set-, expressing the Ly123+Qa1+ surface phenotype, to exert potent suppressive activity, (b) this T-T interaction plays an important role in regulating in vivo immune responses, and (c) this interaction represents an important barrier to protocols intended to augment the immune status of individuals by adoptive (or active) immunotherapy. Our results also indicate that the Ly123+ T-cell set mediating feedback suppression in vivo is sensitive to both low doses of cyclophosphamide and removal of the thymus in adult life. The importance of this T-T interaction to normal, physiologic regulation of the immune system is emphasized by the finding that the major T-cell deficit of NZB mice (an inbred strain of mice that spontaneously develops an autoimmune disorder) is the absence or malfunction of an Ly123+ T-cell set responsible for feedback inhibition.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D008211 Lymphocyte Cooperation T-cell enhancement of the B-cell response to thymic-dependent antigens. Cooperation, Lymphocyte,Cooperations, Lymphocyte,Lymphocyte Cooperations
D008814 Mice, Inbred NZB An inbred strain of mouse that is widely used as a model for AUTOIMMUNE DISEASES such as SYSTEMIC LUPUS ERYTHEMATOSUS. Mice, NZB,Mouse, Inbred NZB,Mouse, NZB,Inbred NZB Mice,Inbred NZB Mouse,NZB Mice,NZB Mice, Inbred,NZB Mouse,NZB Mouse, Inbred
D011828 Radiation Chimera An organism whose body contains cell populations of different genotypes as a result of the TRANSPLANTATION of donor cells after sufficient ionizing radiation to destroy the mature recipient's cells which would otherwise reject the donor cells. Chimera, Radiation,Chimeras, Radiation,Radiation Chimeras
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005246 Feedback A mechanism of communication within a system in that the input signal generates an output response which returns to influence the continued activity or productivity of that system. Feedbacks
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune

Related Publications

H Cantor, and L McVay-Boudreau, and J Hugenberger, and K Naidorf, and F W Shen, and R K Gershon
May 1979, Journal of immunology (Baltimore, Md. : 1950),
H Cantor, and L McVay-Boudreau, and J Hugenberger, and K Naidorf, and F W Shen, and R K Gershon
June 1978, Arthritis and rheumatism,
H Cantor, and L McVay-Boudreau, and J Hugenberger, and K Naidorf, and F W Shen, and R K Gershon
July 1979, The Journal of experimental medicine,
H Cantor, and L McVay-Boudreau, and J Hugenberger, and K Naidorf, and F W Shen, and R K Gershon
January 1984, Survey of immunologic research,
H Cantor, and L McVay-Boudreau, and J Hugenberger, and K Naidorf, and F W Shen, and R K Gershon
July 1983, The Journal of experimental medicine,
H Cantor, and L McVay-Boudreau, and J Hugenberger, and K Naidorf, and F W Shen, and R K Gershon
September 1980, Journal of immunology (Baltimore, Md. : 1950),
H Cantor, and L McVay-Boudreau, and J Hugenberger, and K Naidorf, and F W Shen, and R K Gershon
July 1985, Cellular immunology,
H Cantor, and L McVay-Boudreau, and J Hugenberger, and K Naidorf, and F W Shen, and R K Gershon
May 1979, Journal of immunology (Baltimore, Md. : 1950),
H Cantor, and L McVay-Boudreau, and J Hugenberger, and K Naidorf, and F W Shen, and R K Gershon
February 1981, The Journal of experimental medicine,
H Cantor, and L McVay-Boudreau, and J Hugenberger, and K Naidorf, and F W Shen, and R K Gershon
June 1991, Clinical immunology and immunopathology,
Copied contents to your clipboard!